本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Relmada Therapeutics, Inc.

4.52
+0.450011.06%
盤後4.570.0499+1.10%19:59 EDT
成交量:262.93萬
成交額:1,178.14萬
市值:4.84億
市盈率:-4.86
高:4.65
開:4.60
低:4.30
收:4.07
52周最高:8.00
52周最低:1.45
股本:1.07億
流通股本:7,816.06萬
量比:1.73
換手率:3.36%
股息:- -
股息率:- -
每股收益(TTM):-0.9300
每股收益(LYR):-1.4535
淨資產收益率:-55.66%
總資產收益率:-32.39%
市淨率:2.34
市盈率(LYR):-3.11

資料載入中...

2023/03/13

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/17

重要事件披露

8-K - Current report
2023/01/09

重要事件披露

8-K - Current report
2023/01/05

重要事件披露

8-K - Current report
2022/12/28

重要事件披露

8-K - Current report
2022/12/20

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/07

重要事件披露

8-K - Current report
2022/11/14

重要事件披露

8-K - Current report
2022/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/10

重要事件披露

8-K - Current report
2022/10/21

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals